Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Uromed (US) launches incontinence device in Germany:

This article was originally published in Clinica

Executive Summary

Uromed (US) is to launch its Reliance Insert incontinence device in Germany this autumn. The single-use, balloon-tipped device is inserted into the urethra with a reusable applicator which, when depressed, inflates the balloon. The insert is removed to allow urination by pulling on a string which deflates the balloon. Average use is expected to be three times daily. The Reliance is indicated for stress urinary incontinence for patients unwilling to undergo surgery or as a stopgap before surgery. UroMed has filed for a 510(k) in the US and hopes to launch the device in other countries this year. Some 8.5 million women in the US suffer urinary incontinence.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT091563

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel